Leerink Partners analyst Michael Cherny downgraded CVS Health (NYSE: CVS) from Outperform to Market Perform with a price target of $60.00.

For an analyst ratings summary and ratings history on CVS Health click here. For more ratings news on CVS Health click here.

Shares of CVS Health closed at $67.71 yesterday.